03.02.04 Other equipment for immunochemistry and immunology
Other equipment for immunochemistry and immunology
03 Diagnostic Tests
03.05 Infectious immunology testing
03.05.02 Microbiological diagnosis, virology, equipment and systems for
Microbiological diagnosis, virology, equipment and systems for
Product category: Diagnostic rapid tests
Alpha-fetoprotein is a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistance of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of alpha-fetoprotein in amniotic fluid is used to measure renal loss of protein to screen for spina bifida and anencephaly.
Alternative names: AFPD; FETA; HPAFP; Alpha-1-Fetoprotein; Alpha-Fetoglobulin
SDIX is a wholly owned subsidiary of OriGene Technologies, specializing in high quality, large-scale GMP antibody production in the U.S.; Delaware and Maine.
For over 25 years, SDIX has been a leading immuno-solutions company, developing results-oriented and innovative antibody-based solutions that enable customers, world-wide, to meet high performance diagnostic and commercialization objectives. All sites are ISO 13485:2016 certified and the manufacturing site in Delaware is FDA and MHRA registered for the manufacture and export of class I IHC reagents and kits.
For IHC applications, over 40 CE-marked IVD reagents are manufactured and sold in the EU and US. Other products include critical reagents such as antibodies to Troponin I, Strep A, CRP, Apo A1, ApoB, Micro-albumin and Calibrators. SDIX also provides both polyclonal and monoclonal antibody development and production services, including long term supply of monoclonal antibodies for IVD and drug development applications as well as polyclonal antibody production in goat, rabbit and other species.
In the life science market, SDIXs technology and capabilities are being used to help discover disease mechanisms, facilitate development of new drugs, and provide antibodies and assays utilized in the diagnosis of disease.